LLMpediaThe first transparent, open encyclopedia generated by LLMs

Medicare Provider Analysis and Review

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Expansion Funnel Raw 59 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted59
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Medicare Provider Analysis and Review
NameMedicare Provider Analysis and Review
TypeHealth data program
Established1980s
CountryUnited States
Administered byCenters for Medicare & Medicaid Services

Medicare Provider Analysis and Review Medicare Provider Analysis and Review is a United States health data program that aggregates inpatient claims to support oversight, reimbursement, and research for Medicare and Medicaid populations. The dataset has been used by agencies, universities, and think tanks for policy evaluation, quality measurement, and payment reform analysis across diverse settings such as hospitals, academic centers, and integrated systems. Major users include federal agencies, state departments, research universities, and private organizations engaged in health services research, payment reform, and regulatory compliance.

Overview

The program assembles standardized hospital inpatient claims and discharge abstracts maintained by the Centers for Medicare & Medicaid Services, the Department of Health and Human Services, the Office of Management and Budget, and related agencies to enable analyses by institutions such as the Johns Hopkins University, the Harvard T.H. Chan School of Public Health, the RAND Corporation, the Brookings Institution, and the Kaiser Family Foundation. Data elements include patient demographics, diagnosis codes from the International Classification of Diseases, procedure codes from the Current Procedural Terminology, provider identifiers aligned with the National Provider Identifier system, and facility characteristics comparable to registries like the American Hospital Association. The dataset has supported projects by the Agency for Healthcare Research and Quality, the National Institutes of Health, and state health departments such as the California Department of Public Health and the New York State Department of Health.

Program History and Development

The dataset originated amid reforms in the 1980s under programs linked to the Social Security Act amendments and early prospective payment experiments involving the Health Care Financing Administration and the Prospective Payment System. Subsequent modernization linked the collection to initiatives led by the Centers for Medicare & Medicaid Services, legislative actions from the United States Congress, and oversight by committees including the House Ways and Means Committee and the Senate Finance Committee. Academic collaborations included projects with the University of Michigan, the Columbia University Mailman School of Public Health, and the University of California, San Francisco to refine case-mix and risk-adjustment methods influenced by work from researchers at Yale University and the University of Pennsylvania.

Data Collection and Methodology

Claims aggregation follows standardized fields anchored in coding systems such as the ICD-9 and the ICD-10, with procedure mapping to the Current Procedural Terminology and billing constructs harmonized with the Centers for Medicare & Medicaid Services claims processing. Sampling and weighting approaches reference methodologies developed at institutions like the Agency for Healthcare Research and Quality and analytic frameworks used by the World Health Organization and the Organisation for Economic Co-operation and Development. Data cleaning, de-duplication, and encryption practices mirror standards from the National Institutes of Health data sharing policies and the Office for Civil Rights guidance on the HIPAA. Risk adjustment and case-mix methodologies have been compared to approaches from the Charlson Comorbidity Index development team and analytic tools used by the Clinical Classifications Software and researchers at the Mayo Clinic.

Public Use Files and Data Access

Public use files derived from the program are disseminated under access models resembling releases by the Centers for Medicare & Medicaid Services and restricted-use agreements similar to those from the National Center for Health Statistics and the Research Data Center run by the National Bureau of Economic Research. Data sharing and researcher access policies align with protocols from the National Institutes of Health and data governance frameworks promoted by the Office of the National Coordinator for Health Information Technology. Secondary users have included teams at the University of California, Los Angeles, the University of Washington, the University of Pittsburgh, and private firms that partner with the Department of Veterans Affairs for comparative effectiveness research. Data linkage projects have joined these files with registries like the Surveillance, Epidemiology, and End Results Program and administrative data from state all-payer databases.

Impact on Healthcare Quality and Policy

Analyses using the dataset have informed payment reforms such as the Hospital Readmissions Reduction Program, value-based purchasing initiatives shaped by the Affordable Care Act, and quality measurement frameworks advanced by the National Quality Forum. Research published by teams at the Harvard Medical School, the University of Chicago, and the Stanford University School of Medicine has used the files to evaluate outcomes, cost trajectories, and geographic variation comparable to work on regional differences by the Dartmouth Atlas of Health Care. Findings have influenced legislation considered by the United States Congress and guidance issued by the Centers for Medicare & Medicaid Services and the Department of Health and Human Services.

Criticisms and Controversies

Critiques by scholars at the Brookings Institution, the Urban Institute, and the Commonwealth Fund have highlighted limitations including coding variability tied to changes in the International Classification of Diseases, lags in release schedules noted by the Government Accountability Office, and privacy concerns raised with respect to policies from the Office for Civil Rights. Debates involving stakeholders such as the American Hospital Association, the Association of American Medical Colleges, and patient advocacy groups have focused on data granularity, provider attribution, and the implications for payment policy debated before the House Committee on Energy and Commerce and the Senate Health, Education, Labor and Pensions Committee.

Category:United States health programs